Lion Point Capital, LP SNDX Holdings History
Lion Point Capital, LP's Syndax Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Lion Point Capital, LP held 55,000.00 shares of Syndax Pharmaceuticals Inc(SNDX), totaling $675,680.00. This investment constitutes 4.31% of their stock portfolio, and Lion Point Capital, LP now holds 0.06% of the outstanding Syndax Pharmaceuticals Inc(SNDX) stock.
The initial trade took place in 2023Q2. And since then Lion Point Capital, LP has made 3 purchases of SNDX, at an average price of $20.99, for a total of 73,800.00 shares. In addition, there have been 1 sales at an average price of $20.66 for 18,800.00 shares. Based on historical transaction data and SNDX's current price of $8.73, Lion Point Capital, LP's estimated gain on his SNDX holdings is $-680,421.00, reflecting a -43.93% gain to date.
Lion Point Capital, LP SNDX ($8.73) Holding Chart
Lion Point Capital, LP SNDX ($8.73) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1